Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?

To: Gulo who wrote (3460)	10/27/2003 8:08:42 AM
From: Arthur Radley	Respond to of 23958

Gulo...I think I clearly indicated there was no certainty that the drug was Surfaxin. I was merely drawing the parallel to Surfaxin and its application to such treatments. My referencing the inflammatory application comes from literature that I've read....my whole point of investing in DSCO is that there is a need for a product of its kind. Maybe you could take up this issue with DSCO and the FDA, because for sure they (DSCO) references the application of their drug to such events. For example....Page 6 of their annual report..."Scientific data supports that the therapuetic use of surfactants in aerosol form has the ability to reestablish airway patency, improve pulmonary mechanics, and ACT AS AS AN ANTI-INFLAMMATORY. I'm sure that the FDA would have an issue with DSCO if what you say is true and not as they state in their SEC filings and data that they submit to them (FDA).

To: Gulo who wrote (3460)	10/27/2003 10:10:55 AM
From: Arthur Radley	Read Replies (1) \| Respond to of 23958

Gulo, The only reason that I mentioned DSCO is that the Phase III results coming up within a few weeks should give it a nice pop...IF the results are what I expect. However, we all know that Phase testing is wrought with failures for "promising" drugs. Granted...I have a sizeable holding in DSCO, but my favorite longer term holding is MICU. From you posting it appears you have an understanding of the medical arena, and surely have an appreciation for the over use of drugs that we North Americans demonstrate. I'm mainly speaking of the overuse of antibotics and the immunity that we are developing. Also, the scary details of the deaths occuring in our hospitals because of infections. This is why I think MICU has a great future with their current drug before the FDA for approval and their pipeline. With FDA approval in early 04', I think MICU could be a "whoa nellie!" as well as a Yeehawer!! Any thoughts on MICU?